HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Item, C. B. Articles by Stöckler-Ipsiroglu, S. Search for Related Content PubMed PubMed Citation Articles by Item, C. B. Articles by Stöckler-Ipsiroglu, S. Related Collections Molecular Diagnostics and Genetics

Denaturing Gradient Gel Electrophoresis for the Molecular Characterization of Six Patients with Guanidinoacetate Methyltransferase Deficiency

¹ Department of Pediatrics, University Hospital and General Hospital (AKH), Währingerstrasse 18-20, A-1090 Vienna, Austria

² Department of Pediatrics, University Hospital, D-69120 Heidelberg, Germany

³ Institute of Child Health, University College, WC1N 2AP London, United Kingdom

⁴ Dipartimento di Scienze Neurologiche e Psichiatriche dell'Età Evolutiva, Università "La Sapienza", 00185 Rome, Italy

⁵ VU University Medical Center, De Boelelaan 1117, 1007 Amsterdam, The Netherlands

^aauthor for correspondence: fax 43-1-4063484, e-mail stoeckler@metabolic-screening.at

Guanidinoacetate methyltransferase [(GAMT); EC 2.1.1.2] deficiency is the first recognized inborn error of creatine biosynthesis, manifesting in infancy with severe neurologic symptoms such as epilepsy, mental retardation, muscular hypotonia, and progressive extrapyramidal movement disorder (1). Patients with GAMT deficiency have shown favorable responses to oral supplementation of creatine-monohydrate, but complete reversal of symptoms has not been observed (2). Biochemical findings include high urinary excretion of guanidinoacetate (the immediate precursor of creatine and substrate of GAMT), low urinary excretion of creatinine [conversion product of intracellular creatine; see Ref. (3)], and depletion of creatine in brain and muscle (4). After assessing two index patients (5)(6), we aimed to establish methods for the noninvasive molecular diagnosis of GAMT deficiency. We recently developed a radiochemical method for the determination of GAMT activity in cultured skin fibroblasts and in virus-transformed lymphoblasts (7). Here we report a denaturing gradient gel electrophoresis (DGGE) technique for the screening of mutations in the GAMT gene in DNA extracted from dried-blood spot filter-paper samples and from fibroblasts and virus-transformed lymphoblasts.

Three index patients with mutations confirmed by techniques other than DGGE [P1, P2, and P6; see Refs. (5), (8)] and three new patients (P3, P4, and P5) with undetectable GAMT activity but unknown GAMT deficiency mutations (9)(10) were investigated. Details of the patient studies are summarized in Table 1 , and the locations and frequencies of the mutations identified in these patients are shown in Fig. 1 .

References

The following articles in journals at HighWire Press have cited this article:

				S. Mercimek-Mahmutoglu, S. Stoeckler-Ipsiroglu, A. Adami, R. Appleton, H. C. Araujo, M. Duran, R. Ensenauer, E. Fernandez-Alvarez, P. Garcia, C. Grolik, et al. GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis Neurology, August 8, 2006; 67(3): 480 - 484. [Abstract] [Full Text] [PDF]